Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-012338

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Donald E Bobo Jr.
Officer — CVP, Heart Valve Therapy
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 6:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 14, 2015A2,225$0.00A21,439D
Common StockF3holding———6,097I401(k)

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F4$130.56May 14, 2015A22,100AMay 14, 2016May 13, 2022Common Stock22,10022,100D
Performance RightsF5,F2—May 14, 2015A2,775A—May 31, 2018Common Stock2,7752,775D

Explanation of responses